Fundraising Fox
/Companies
Sign in

Enara Bio

9 known investors

Find your way into Enara Bio

Sign up to see every warm intro you have to Enara Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Enara Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform. The company serves cancer patients and collaborates with pharmaceutical companies and academic research institutions.

BiotechDeep TechMedical Devices

Founders & leadership

GK
George KassiotisCo-founder
DP
Drew PardollCo-founder
HAHouman Ashrafian
Houman AshrafianCo-founderManaging Partner at SV Health Investors
KPKevin Pojasek
Kevin PojasekExecutive Officer at KALA BIO

Investors · 9

Samsara BioCapital✓ confirmed by Enara BioMenlo Park

How we know: Samsara BioCapital's portfolio page · the company's own site · biospace.com · Not right? Tell us

SV Health Investors✓ confirmed by Enara BioLondon · $1M – $20M

How we know: the company's own site · SV Health Investors's portfolio page · biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us

Pfizer Ventures✓ confirmed by Enara Bio

How we know: the company's own site · biospace.com · Not right? Tell us

Dementia Discovery Fundlisted by Dementia Discovery FundLondon

How we know: Dementia Discovery Fund's portfolio page · Not right? Tell us

M Ventureslisted by M VenturesAmsterdam · $10.8M

How we know: M Ventures's portfolio page · biospace.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 2

Francis Crick InstituteThe Francis Crick Institute

Funding

SEC filings, press & company announcements

$32.5M disclosed across 1 of 2 rounds · 2024–2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Enara Bio raises $53M Series B — Biotech funding UK 2026 | Scaling Europescalingeurope.co.uk · Jun 2026Enara Bio secured US$32,500,000 in an amazing growth funding round. | Startupmagstartupmag.co.uk · Oct 2024Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens® - BioSpacebiospace.com · Oct 2024

Frequently asked questions

What does Enara Bio do?
Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform. The company serves cancer patients and collaborates with pharmaceutical companies and academic research institutions.
Who founded Enara Bio?
Enara Bio was founded by George Kassiotis, Drew Pardoll, Houman Ashrafian.
Who are Enara Bio's investors?
Enara Bio's investors include RA Capital, Samsara BioCapital, SV Health Investors, Pfizer Ventures, Dementia Discovery Fund, M Ventures, Pfizer Venture Investments.
How much funding has Enara Bio raised?
Enara Bio has disclosed $32.5M raised across 1 of its 2 known rounds.